Chronic nicotine treatment increases GABAergic input to striatal neurons

NeuroReport

Volumn 17, Issue 5, 2006, Pages 537-540

  Miura, Masami ^a,b   Ishii, Katsuyoshi ^a   Aosaki, Toshihiko ^b   Sumikawa, Katumi ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

Author keywords

aminobutyric acid; Endogenous acetylcholine; Inhibitory postsynaptic current; Medium sized spiny projection neuron; Tobacco smoking; Whole cell recording

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; 3 AMINO 2 (3 CARBOXYPROPYL) 6 (4 METHOXYPHENYL)PYRIDAZINIUM BROMIDE; 3 AMINOPROPYL(METHYL)PHOSPHINIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; 4 AMINOBUTYRIC ACID A RECEPTOR STIMULATING AGENT; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; AMPA RECEPTOR ANTAGONIST; BICUCULLINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; DIHYDRO BETA ERYTHROIDINE; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR BLOCKING AGENT; METHYLLYCACONITINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NICOTINE; PHOSPHATE BUFFERED SALINE; SULPIRIDE;

ADDICTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN SLICE; CIGARETTE SMOKING; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; MOUSE; NEUROTRANSMISSION; NONHUMAN; PATCH CLAMP; PATHOPHYSIOLOGY; PRIORITY JOURNAL; TOBACCO DEPENDENCE;

ANIMALS; EXCITATORY POSTSYNAPTIC POTENTIALS; GABA AGONISTS; GABA ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; MALE; MEMBRANE POTENTIALS; MICE; MICE, INBRED C57BL; NEOSTRIATUM; NEURONS; NICOTINE; NICOTINIC AGONISTS; PATCH-CLAMP TECHNIQUES; STIMULATION, CHEMICAL;

EID: 33645122504     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.wnr.0000204984.21748.e3     Document Type: Article

References (25)

1. Graybiel AM, Aosaki T, Flaherty AW, Kimura M. The basal ganglia and adaptive motor control. Science 1994; 265:1826-1831.
2. Kimura M. Role of basal ganglia in behavioral learning. Neurosci Res 1995; 22:353-358.
3. Gerdeman GL, Partridge JG, Lupica CR, Lovinger DM. It could be habit forming: drugs of abuse and striatal synaptic plasticity. Trends Neurosci 2003; 26:184-192.
4. Nguyen HN, Rasmussen BA, Perry DC. Subtype-selective up-regulation by chronic nicotine of high-affinity nicotinic receptors in rat brain demonstrated by receptor autoradiography. J Pharmacol Exp Ther 2003; 307:1090-1097.
5. Nuutinen S, Ahtee L, Tuominen RK. Time and brain region specific upregulation of low affinity neuronal nicotinic receptors during chronic nicotine administration in mice. Eur J Pharmacol 2005; 515:83-89.
6. Buisson B, Bertrand D. Chronic exposure to nicotine upregulates the human α4β2 nicotinic acetylcholine receptor function. J Neurosci 2001; 21:1819-1829.
7. Yu ZJ, Wecker L. Chronic nicotine administration differentially affects neurotransmitter release from rat striatal slices. J Neurochem 1994; 63:186-194.
8. Grady SR, Grun EU, Marks MJ, Collins AC. Pharmacological comparison of transient and persistent [3H]dopamine release from mouse striatal synaptosomes and response to chrome L-nicotine treatment. J Pharmacol Exp Ther 1997; 282:32-43.
9. Risso F, Parodi M, Grilli M, Molfino F, Raiteri M, Marchi M. Chronic nicotine causes functional upregulation of ionotropic glutamate receptors mediating hippocampal noradrenaline and striatal dopamine release. Neurochem Int 2004; 44:293-301.
10. Bolam JP, Hanley JJ, Booth PA, Bevan MD. Synaptic organisation of the basal ganglia. J Anat 2000; 196:527-542.
11. Kawaguchi Y, Wilson CJ, Augood SJ, Emson PC. Striatal interneurones: chemical, physiological and morphological characterization. Trends Neurosci 1995; 18:527-535.
12. Aosaki T, Kimura M, Graybiel AM. Temporal and spatial characteristics of tonically active neurons of the primate's striatum. J Neurophysiol 1995; 73:1234-1252.
13. Bennett BD, Wilson CJ. Spontaneous activity of neostriatal cholinergic interneurons in vitro. J Neurosci 1999; 19:5586-5596.
14. Kaneko S, Hikida T, Watanabe D, Ichinose H, Nagatsu T, Kreitman RJ, et al. Synaptic integration mediated by striatal cholinergic interneurons in basal ganglia function. Science 2000; 289:633-637.
15. Lu Y, Grady S, Marks MJ, Picciotto M, Changeux JP, Collins AC. Pharmacological characterization of nicotinic receptor-stimulated GABA release from mouse brain synaptosomes. J Pharmacol Exp Ther 1998; 287:648-657.
16. Kofalvi A, Sperlagh B, Zelles T, Vizi ES. Long-lasting facilitation of 4-amino-n-[2,3-(3)H]butyric acid ([(3)H]GABA) release from rat hippocampal slices by nicotinic receptor activation. J Pharmacol Exp Ther 2000; 295:453-462.
17. Yu H, Matsubayashi H, Amano T, Cai J, Sasa M. Activation by nicotine of striatal neurons receiving excitatory input from the substantia nigra via dopamine release. Brain Res 2000; 872:223-226.
18. Suzuki T, Miura M, Nishimura K, Aosaki T. Dopamine-dependent synaptic plasticity in the striatal cholinergic interneurons. J Neurosci 2001; 21:6492-6501.
19. Zhou FM, Wilson CJ, Dani JA. Cholinergic interneuron characteristics and nicotinic properties in the striatum. J Neurobiol 2002; 53:590-605.
20. Fitzpatrick JS, Akopian G, Walsh JP. Short-term plasticity at inhibitory synapses in rat striatum and its effects on striatal output. J Neurophysiol 2001; 85:2088-2099.
21. Seabrook GR, Howson W, Lacey MG. Subpopulations of GABA-mediated Synaptic potentials in slices of rat dorsal striatum are differentially modulated by presynaptic GABAB receptors. Brain Res 1991; 562:332-334.
22. Zoli M, Moretti M, Zanardi A, McIntosh JM, Clementi F, Gotti C. Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum. J Neurosci 2002; 22:8785-8789.
23. Jones IW, Bolam JP, Wonnacott S. Presynaptic localisation of the nicotinic acetylcholine receptor β2 subunit immunoreactivity in rat nigrostriatal dopaminergic neurons. J Comp Neurol 2001; 439:235-247.
24. Pakkanen JS, Jokitalo E, Tuominen RK. Up-regulation of α2 and β7 subunit containing nicotinic acetylcholine receptors in mouse striatum at cellular level. Eur J Neurosci 2005; 21:2681-2691.
25. Mogg AJ, Whiteaker P, McIntosh JM, Marks M, Collins AC, Wonnacott S. Methyllycaconitine is a potent antagonist of alpha-conotoxin-MII-sensitive presynaptic nicotinic acetylcholine receptors in rat striatum. J Pharmacol Exp Ther 2002; 302:197-204.